Originally published In Press as doi:10.1074/mcp.T500039-MCP200 on March 21, 2006.
Molecular & Cellular Proteomics 5:1338-1347, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.
Technology
Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass Spectrometry*
Masaya Ono ,
Miki Shitashige ,
Kazufumi Honda ,
Tomohiro Isobe ,
Hideya Kuwabara ,
Hirotaka Matsuzuki ,
Setsuo Hirohashi and
Tesshi Yamada ,¶
From the Chemotherapy Division and Cancer Proteomics Project, National Cancer Center Research Institute, Tokyo 104-0045 and BioBusiness Group, Mitsui Knowledge Industry, Tokyo 164-8555, Japan
We developed an integrated platform consisting of machinery and software modules that can apply vast amounts of data generated by nanoflow LC-MS to differential protein expression analyses. Unlabeled protein samples were completely digested with modified trypsin and separated by low speed (200 nl/min) one-dimensional HPLC. Mass spectra were obtained every 1 s by using the survey mode of a hybrid Q-TOF mass spectrometer and displayed in a two-dimensional plane with m/z values along the x axis, and retention time was displayed along the y axis. The time jitter of nano-LC was adjusted using newly developed software based on a dynamic programming algorithm. The comprehensiveness (60,000160,000 peaks above the predetermined threshold detectable in 60-µg cell protein samples), reproducibility (average coefficient of variance of 0.350.39 and correlation coefficient of over 0.92 between duplicates), and accurate quantification with a wide dynamic range (over 103) of our platform warrant its application to various types of experimental and translational proteomics.
¶ To whom correspondence should be addressed: Chemotherapy Division, National Cancer Center Research Inst., Tokyo 104-0045, Japan. Tel.: 81-3-3542-2511; Fax: 81-3-3547-6045; E-mail: tyamada{at}gan2.res.ncc.go.jp

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Matsubara, M. Ono, A. Negishi, H. Ueno, T. Okusaka, J. Furuse, K. Furuta, E. Sugiyama, Y. Saito, N. Kaniwa, et al.
Identification of a Predictive Biomarker for Hematologic Toxicities of Gemcitabine
J. Clin. Oncol.,
May 1, 2009;
27(13):
2261 - 2268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ocak, P. Chaurand, and P. P. Massion
Mass Spectrometry-based Proteomic Profiling of Lung Cancer
Proceedings of the ATS,
April 15, 2009;
6(2):
159 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. FATIMA, D. CHELIUS, B. T. LUKE, M. YI, T. ZHANG, S. STAUFFER, R. STEPHENS, P. LYNCH, K. MILLER, T. GUSZCZYNSKI, et al.
Label-free Global Serum Proteomic Profiling Reveals Novel Celecoxib-modulated Proteins in Familial Adenomatous Polyposis Patients
Cancer Genomics Proteomics,
January 1, 2009;
6(1):
41 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wang, J. You, K. G. Bemis, T. J. Tegeler, and D. P. G. Brown
Label-free mass spectrometry-based protein quantification technologies in proteomic analysis
Brief Funct Genomic Proteomic,
September 1, 2008;
7(5):
329 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Stylianou, J. P. Affourtit, K. R. Shockley, R. Y. Wilpan, F. A. Abdi, S. Bhardwaj, J. Rollins, G. A Churchill, and B. Paigen
Applying Gene Expression, Proteomics and Single-Nucleotide Polymorphism Analysis for Complex Trait Gene Identification
Genetics,
March 1, 2008;
178(3):
1795 - 1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|